May support evaluation Common Eligibility Factors BMI of 30 or greater BMI of 27 or greater with a related health condition Prior lifestyle efforts without durable results Ability to attend monitoring and report symptoms Willingness to support nutrition, movement, and maintenance Needs more review Reasons to Avoid, Delay, or Modify Treatment Pregnancy, planned pregnancy, or breastfeeding Personal or family history of medullary thyroid carcinoma or MEN2 for Wegovy/Zepbound Severe gastroparesis or significant gastrointestinal disease Active or unstable eating disorder Prior serious allergy to the medicine Inability to maintain fluid or nutrition Medication interactions or uncontrolled illness These medicines are not intended for cosmetic weight loss The goal is treatment of obesity or clinically significant overweight-related risknot rapid loss of a few pounds for an event
Microbial signals can also affect epithelial stress-response pathways
Cheese in small portions (1 ounce or about one slice) is also well-tolerated due to its low lactose content and high nutrient density
[3] If you are planning to conceive, discuss discontinuation and alternative management strategies with your healthcare provider
g , h , Effect of Cys and GSH concentrations on chiral morphology
You can make informed treatment decisions by knowing the current alternatives and the future timeline for generics